Top compounds associated with response to C20orf141


Feature Type Standardized
Nominal ANOVA
mRNA R428 CTRPv2 pan-cancer AAC -0.091 0.03
mRNA BRD-M00053801 CTRPv2 pan-cancer AAC -0.1 0.03
mRNA cediranib CTRPv2 pan-cancer AAC -0.11 0.03
mRNA BRD-K71935468 CTRPv2 pan-cancer AAC 0.078 0.03
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC 0.078 0.04
mRNA PIK-93 CTRPv2 pan-cancer AAC -0.071 0.04
mRNA bid1870 gCSI pan-cancer AAC 0.11 0.04
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.04
mRNA simvastatin CTRPv2 pan-cancer AAC 0.078 0.04
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.07 0.04
Download CSV